Your browser doesn't support javascript.
loading
Fibroblast growth factor 1 ameliorates diabetes-induced splenomegaly via suppressing inflammation and oxidative stress.
Wu, Yanqing; Jia, Gaili; Wang, Beini; Xiong, Jun; Xu, Jingyu; Zheng, Peipei; Yuan, Yuan; Li, Yiyang; Jiang, Ting; Al Mamun, Abdullah; Xu, Ke; Liu, Yaqian; Cao, Hong; Xiao, Jian.
Afiliación
  • Wu Y; The Institute of Life Sciences, Engineering Laboratory of Zhejiang Province for Pharmaceutical Development of Growth Factors, Biomedical Collaborative Innovation Center of Wenzhou, Wenzhou University, Wenzhou, Zhejiang, 325035, China; Department of Anesthesiology, The Second Affiliated Hospital and
  • Jia G; Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, 325027, China.
  • Wang B; Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, 325027, China.
  • Xiong J; Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, 325027, China.
  • Xu J; The Institute of Life Sciences, Engineering Laboratory of Zhejiang Province for Pharmaceutical Development of Growth Factors, Biomedical Collaborative Innovation Center of Wenzhou, Wenzhou University, Wenzhou, Zhejiang, 325035, China.
  • Zheng P; Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, 325027, China.
  • Yuan Y; Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, 325027, China.
  • Li Y; Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, 325027, China.
  • Jiang T; Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, 325027, China.
  • Al Mamun A; Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, 325027, China.
  • Xu K; The Institute of Life Sciences, Engineering Laboratory of Zhejiang Province for Pharmaceutical Development of Growth Factors, Biomedical Collaborative Innovation Center of Wenzhou, Wenzhou University, Wenzhou, Zhejiang, 325035, China.
  • Liu Y; Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, 325027, China.
  • Cao H; Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, 325027, China. Electronic address: caohongwz@163.com.
  • Xiao J; Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, 325027, China. Electronic address: xfxj2000@126.com.
Biochem Biophys Res Commun ; 528(2): 249-255, 2020 07 23.
Article en En | MEDLINE | ID: mdl-32482386

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esplenomegalia / Factor 1 de Crecimiento de Fibroblastos / Estrés Oxidativo / Diabetes Mellitus Experimental / Inflamación Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esplenomegalia / Factor 1 de Crecimiento de Fibroblastos / Estrés Oxidativo / Diabetes Mellitus Experimental / Inflamación Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Año: 2020 Tipo del documento: Article